Prot# TAK-700_201: A Phase 1/2, Open-Label, Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of TAK-700 in Metastatic, Androgen-Independent Prostate Cancer Subjects
- Kuzel, Timothy Michael (PD/PI)
Project: Research project
Project: Research project